CD274 and triple-negative breast carcinoma: When human triple-negative breast cancer cells (MDA-MB-231 and BT-549) were transfected with miR-4759, treated with anti-PD-L1 and co-cultured with peripheral blood mononuclear cells, the in vitro cell killing assays showed enhanced tumor cytotoxicity [40].